|
Re: Resverlogix Announces Filing of Quarterly Financial Statements and Management's Discussion & Analysis
|
4
|
Resverlogix Corp.
|
Sep 14, 2017 12:12PM
|
|
Re: Renal trial delayed (again)
|
4
|
Resverlogix Corp.
|
Sep 30, 2017 12:35PM
|
|
Re: AGM 2018 - Masila Notes
|
4
|
Resverlogix Corp.
|
Jun 13, 2019 09:54AM
|
|
Re: Clarification on BETonMACE baseline data
|
4
|
Resverlogix Corp.
|
Sep 06, 2019 09:35AM
|
|
Re: Futility Analysis Q&A With Company Source
|
4
|
Resverlogix Corp.
|
Feb 18, 2016 09:06PM
|
|
Re: Phase 4 - Appraently for drugs already approved for marketing.....
|
4
|
Resverlogix Corp.
|
Jan 27, 2019 11:06PM
|
|
Re: Could Apabelalone ever replace statins,....
|
4
|
Resverlogix Corp.
|
May 13, 2019 07:44AM
|
|
Re: News !!!
|
4
|
Resverlogix Corp.
|
Feb 27, 2018 11:59AM
|
|
Zenith and RVX presenting at Biotech Showcase Jan 11-13 and Zenith AGM Jan 7
|
4
|
Zenith Epigenetics
|
Dec 06, 2015 09:18PM
|
|
Re: Marching on to March events
|
4
|
Zenith Epigenetics
|
Mar 12, 2018 12:15PM
|
|
Re: Slides from Resverlogix Corporate Update 6/13/16
|
4
|
Resverlogix Corp.
|
Jun 13, 2016 01:41PM
|
|
Re: We might already be at 125 events....
|
4
|
Resverlogix Corp.
|
Oct 25, 2017 03:59PM
|
|
Re: Question on Rosuvastatin versus Astorvastatin
|
4
|
Resverlogix Corp.
|
Sep 06, 2019 09:40AM
|
|
Re: AHA Late Breaker!
|
4
|
Resverlogix Corp.
|
Sep 20, 2019 12:32PM
|
|
Re: Zenith Notice of Meeting and Management Information Circular
|
4
|
Zenith Epigenetics
|
Dec 06, 2015 09:23PM
|
|
BET Inhibition Improves NASH and Liver Fibrosis
|
4
|
Resverlogix Corp.
|
Nov 24, 2018 11:30PM
|
|
Re: Recent ESC 2017 meeting and Steve Nissans comments
|
4
|
Resverlogix Corp.
|
Sep 11, 2017 10:19AM
|
|
Re: CANTOS and CIRT
|
4
|
Resverlogix Corp.
|
Nov 14, 2017 03:51PM
|
|
Apabetalone as a cancer drug?
|
4
|
Resverlogix Corp.
|
May 29, 2019 10:45AM
|
|
Re: AGM 2018 - Masila Notes
|
4
|
Resverlogix Corp.
|
Jun 13, 2019 10:30AM
|
